Harnessing the potential of Archaea – Training Europe’s next visionaries for an innovative and sustainable future
Akronym
ARCTECH
Bidragets beskrivning
Archaea form one of the three domains of life, next to bacteria and eukaryotes. Archaea have unique cellular characteristics that allow them to thrive in extreme environments, for example at high pressures, salt concentrations or temperatures. Although their biochemical and metabolic properties show great potential for a wide range of biotechnological applications, our lack of knowledge about the structure and function of the archaeal cell surface and its role in formation of communities, such as biofilms, is currently hampering the large-scale industrial use of these organisms. Indeed, several prominent questions remain unanswered due to the small scientific community working in the field, and the lack of methods and technologies enabling research under extreme conditions.
ARCTECH proposes the first training initiative on archaea, aiming to foster the next generation of European visionaries in ‘fundamental archaeal research and their application in biotechnology’. The 11 Doctoral Candidates (DCs) will address key knowledge gaps and develop methods and technologies for archaeal research, which are needed to unleash the industrial potential that archaea hold. The scientific outcomes of ARCTECH will be applicable to several biotech areas, such as Green Energy production, Sustainable Biomaterials, Biocorrosion, Enzyme production and Drug Delivery.
This project will directly impact the European Higher Education Sector as the first research training initiative embarking into the unchartered world of archaea. The DCs will be trained by world experts from European academic and industrial institutions, benefiting from strong interdisciplinary exposure (e.g. microbiology, bioimaging, biogas production). These entrepreneurial, innovative, and resilient DCs will be of great value both to the academic and non-academic sectors, bringing unique capacity to inspire/spawn new fields of innovation in European industries.
Visa merStartår
2024
Slutår
2028
Beviljade finansiering
INTERHERENCE GMBH (DE)
260 539.2 €
Participant
MICROBIFY GMBH (DE)
260 539.2 €
Participant
MEDIZINISCHE UNIVERSITAT GRAZ (AT)
540 662.4 €
Participant
ALBERT-LUDWIGS-UNIVERSITAET FREIBURG (DE)
260 539.2 €
Participant
UNIVERSITAET DUISBURG-ESSEN (DE)
260 539.2 €
Participant
THE UNIVERSITY OF EXETER (UK)
Participant
NOVOZYMES A/S (DK)
Participant
UNIVERSITA DEGLI STUDI DI NAPOLI FEDERICO II (IT)
259 437.6 €
Participant
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH (CH)
Participant
RIJKSUNIVERSITEIT GRONINGEN (NL)
548 740.8 €
Coordinator
Beviljat belopp
2 677 486 €
Finansiär
Europeiska unionen
Typ av finansiering
HORIZON TMA MSCA Doctoral Networks
Ramprogram
Horizon Europe (HORIZON)
Utlysning
Programdel
Marie Skłodowska-Curie Actions (MSCA) (11677Tema
MSCA Doctoral Networks 2022 (HORIZON-MSCA-2022-DN-01-01Utlysnings ID
HORIZON-MSCA-2022-DN-01 Övriga uppgifter
Finansieringsbeslutets nummer
101120407